Health ❯Pharmaceuticals ❯Drug Development

Clinical Trials

Obesity Treatments Simufilam Lenacapavir Semaglutide Molecular Therapy Regulatory Affairs Rare Diseases Gastroparesis Long-acting Injectables Mental Health

AstraZeneca’s Baxdrostat Delivers Significant Blood Pressure Reductions in Phase 3 Trial for Resistant Hypertension

Data from the study are being readied for regulatory submission ahead of an August presentation at the European Society of Cardiology Congress.

AI-Powered Discovery Yields WYS-694, a Broad-Spectrum Coronavirus Antiviral

AI-Designed Rentosertib Improves Lung Function in Phase IIa IPF Trial

Human Antibodies from Snakebite Hobbyist Pave Way for Broad-Spectrum Antivenom

Merck Announces €3 Billion Acquisition of Springworks Therapeutics

Cargo Therapeutics Ceases Operations Following Clinical and Financial Setbacks

Ebola Pill Shows Promise in Monkey Trials, Raising Hopes for Human Treatment

Annual HIV Prevention Injection Shows Promise in Early Safety Trials

Johnson & Johnson to Acquire Intra-Cellular Therapies in $14.6 Billion Deal

Eli Lilly's Oral Drug Shows Promise in Lowering Genetic Cholesterol

Xenon Pharmaceuticals to Showcase at BofA CNS Therapeutics Conference

UCLA Researchers Develop Molecule That Restores Memory in Alzheimer's Model Mice

New HIV Drug Could Revolutionize Prevention at Just $40 Annually

Alnylam's Heart Drug Shows Promising Phase-3 Results, Boosting Stock

Breakthrough in Male Birth Control: Reversible, Non-Hormonal Pill Shows Promise

Viking Therapeutics' New Weight Loss Drug Shows Promising Trial Results